Comments by Microbiologists for Interpreting Antimicrobial Susceptibility Testing and Improving the Appropriateness of Antibiotic Therapy in Community-Acquired Urinary Tract Infections: A Randomized Double-Blind Digital Case-Vignette Controlled Superiority Trial.

antibiotic prescribing antimicrobial stewardship appropriateness digital trial primary care urinalysis urinary tract infection

Journal

Antibiotics (Basel, Switzerland)
ISSN: 2079-6382
Titre abrégé: Antibiotics (Basel)
Pays: Switzerland
ID NLM: 101637404

Informations de publication

Date de publication:
02 Aug 2023
Historique:
received: 20 06 2023
revised: 15 07 2023
accepted: 28 07 2023
medline: 26 8 2023
pubmed: 26 8 2023
entrez: 26 8 2023
Statut: epublish

Résumé

In primary care, urinary tract infections (UTIs) account for the majority of antibiotic prescriptions. Comments from microbiologists on interpreting the antimicrobial susceptibility testing (AST) profile for urinalysis were made to improve the prescription of antibiotics. We aimed to explore the added value of these comments on the quality of antibiotic prescribing by a superior double-blind digital randomized case-vignette trial among French general practitioners (GPs). One case vignette with (intervention) or without (control) a 'comment' after AST was randomly assigned to GPs. Among 815 participating GPs, 64.7% were women, at an average age of 37 years. Most (90.1%) used a computerized decision support system for prescribing antibiotics. Empirical antibiotic therapy was appropriate in 71.9% (95% CI, 68.8-75.0) of the cases, without differences between arms. The overall appropriateness of targeted antibiotic therapy (primary outcome) was not significantly increased when providing 'comments': 83.4% vs. 79.9% (OR = 1.26, 95% CI, 0.86-1.85). With the multivariate analysis, the appropriateness was improved by 2-folds (OR = 2.38, 95% CI, 1.02-6.16) among physicians working in healthcare facilities. Among digital-affine young general practitioners, the adjunction of a 'comment' by a microbiologist to interpret urinalysis in community-acquired UTIs did not improve the overall level of appropriateness of the targeted antibiotic.

Identifiants

pubmed: 37627692
pii: antibiotics12081272
doi: 10.3390/antibiotics12081272
pmc: PMC10451981
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Curr Opin Infect Dis. 2016 Feb;29(1):73-9
pubmed: 26694621
Eur J Clin Microbiol Infect Dis. 2012 Nov;31(11):3079-83
pubmed: 22722765
JMIR Med Inform. 2022 May 4;10(5):e27795
pubmed: 35507396
Infect Dis Now. 2020 Apr 29;51(1):61-66
pubmed: 32360395
Lancet. 2022 Feb 12;399(10325):629-655
pubmed: 35065702
NPJ Digit Med. 2020 Feb 6;3:17
pubmed: 32047862
Clin Infect Dis. 2019 May 2;68(10):1611-1615
pubmed: 31506700
J Antimicrob Chemother. 2022 Feb 2;77(2):524-530
pubmed: 34747446
Antibiotics (Basel). 2022 Mar 14;11(3):
pubmed: 35326847
Curr Infect Dis Rep. 2019 Jul 24;21(8):29
pubmed: 31342180
Infect Control Hosp Epidemiol. 2011 Oct;32(10):1003-9
pubmed: 21931251
CMAJ. 2007 Oct 9;177(8):877-83
pubmed: 17923655
BMC Fam Pract. 2020 Jul 1;21(1):125
pubmed: 32611320
Lancet Glob Health. 2023 Mar;11(3):e466-e474
pubmed: 36739875
Ann Intern Med. 2004 Nov 16;141(10):771-80
pubmed: 15545677
Int J Antimicrob Agents. 2017 Aug;50(2):258-262
pubmed: 28577933
Nat Microbiol. 2021 Apr;6(4):512-523
pubmed: 33782558
J Antimicrob Chemother. 2020 Aug 1;75(8):2353-2362
pubmed: 32357226
Br J Gen Pract. 2014 Dec;64(629):604-5
pubmed: 25452508
J Antimicrob Chemother. 2003 Feb;51(2):379-84
pubmed: 12562706
Lancet Infect Dis. 2022 Oct;22(10):1408-1409
pubmed: 35870479
Ann Clin Microbiol Antimicrob. 2018 Jun 9;17(1):26
pubmed: 29885657
J Med Internet Res. 2021 Jun 11;23(6):e25741
pubmed: 34114958
BMJ Open. 2019 Feb 22;8(11):e025810
pubmed: 30798294
Infect Dis Clin North Am. 2014 Mar;28(1):1-13
pubmed: 24484571
J Antimicrob Chemother. 2007 Aug;60 Suppl 1:i43-47
pubmed: 17656380
J Antimicrob Chemother. 2014 Oct;69(10):2857-63
pubmed: 24898019
Med Mal Infect. 2018 Aug;48(5):327-358
pubmed: 29759852
Clin Microbiol Rev. 2016 Dec 14;30(1):381-407
pubmed: 27974411
Presse Med. 2015 Mar;44(3):e59-66
pubmed: 25650299
J Antimicrob Chemother. 2011 Jun;66(6):1396-404
pubmed: 21398297
Eur J Clin Microbiol Infect Dis. 2013 May;32(5):627-36
pubmed: 23224717
Fam Pract. 2011 Jun;28(3):294-9
pubmed: 21127022
BMC Health Serv Res. 2020 Mar 6;20(1):185
pubmed: 32143630

Auteurs

Emilie Piet (E)

Department of Infectious Diseases, Centre Hospitalier Annecy Genevois, 74370 Epagny Metz-Tessy, France.

Youssoupha N'Diaye (Y)

Department of Infectious Diseases, Centre Hospitalier Annecy Genevois, 74370 Epagny Metz-Tessy, France.

Johann Marzani (J)

Department of Infectious Diseases, Centre Hospitalier Annecy Genevois, 74370 Epagny Metz-Tessy, France.

Lucas Pires (L)

Clinical Research Department, Centre Hospitalier Annecy Genevois, 74370 Epagny Metz-Tessy, France.

Hélène Petitprez (H)

Microbiological Analysis Department, Centre Hospitalier Annecy Genevois, 74370 Epagny Metz-Tessy, France.

Tristan Delory (T)

Clinical Research Department, Centre Hospitalier Annecy Genevois, 74370 Epagny Metz-Tessy, France.

Classifications MeSH